One-page index of every BPC-157 reference page on Peptides Lab UK — covering mechanism, in-vitro and in-vivo evidence base, analytical quality standards, and protocol references for laboratory tissue-research applications research. For in-vitro and preclinical research use only.
What is BPC-157?
BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid pentadecapeptide fragment derived from a protective protein found in human gastric juice. The native sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) is examined in laboratory research for cytoprotective signalling, angiogenic modulation via vascular endothelial growth factor receptor 2 (VEGFR2), and growth-factor-receptor activation in tissue-research applications models.
BPC-157 is not authorised by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for human medicinal use. It is supplied for laboratory research only.
Mechanism — what BPC-157 is studied for
The published research base on BPC-157 examines several intersecting mechanisms:
- Angiogenic signalling — VEGFR2 modulation has been characterised in endothelial-cell research models, with downstream effects on capillary network formation.
- Nitric oxide pathway interaction — BPC-157 is investigated for nitric-oxide-synthase (eNOS) interaction in endothelial-cell research.
- Growth-factor-receptor activation — research models have characterised effects on EGF and FGF pathway signalling in fibroblast and tendon-cell cultures.
- Cytoprotection — gastric mucosal cytoprotection research underpins the original BPC compound family.
- Connective-tissue research — laboratory tendon-cell and ligament-cell models examine BPC-157 effects on type-I collagen expression.
The above descriptions reflect mechanistic research observations and do not constitute medicinal claims. BPC-157 is not authorised for human use.
Comparison — BPC-157 vs other regenerative research peptides
| Compound | Class | Primary research mechanism | Typical research model |
|---|---|---|---|
| BPC-157 | Pentadecapeptide fragment | VEGFR2 / NO-pathway / cytoprotection | Tendon, ligament, gastric mucosa, vascular |
| TB-500 (Thymosin β-4 fragment) | Tetradecapeptide | Actin-binding, cell migration | Cardiac, dermal, corneal cell research |
| GHK-Cu | Copper tripeptide | Collagen expression, antioxidant | Skin fibroblasts, wound-bed research |
| KPV (α-MSH 11–13) | Tripeptide melanocortin fragment | Anti-inflammatory pathway research | Inflammatory bowel research models |
BPC-157 + TB-500 stack research
The BPC-157 + TB-500 combination is examined in laboratory regenerative research for complementary mechanisms — BPC-157’s angiogenic / VEGFR2 modulation paired with TB-500’s actin-binding and cell-migration profile. Peptides Lab UK supplies both as separate vials and as the KLOW (BPC + TB500 + GHK + KPV) 80 mg blend for laboratory researchers running combination protocols.
Sourcing & analytical standards
Research-grade BPC-157 must be sourced with batch-level analytical certification. The minimum acceptable Certificate of Analysis covers:
- HPLC purity ≥ 98.0% (Peptides Lab UK typical: 99.0–99.7%)
- Mass-spectrometry identity confirmation — observed mass within 0.1 Da of theoretical
- Bacterial endotoxin quantification (LAL assay, < 5 EU/mg)
- Acetate counter-ion quantification for accurate net peptide mass
- Batch / lot number matching the vial label
Peptides Lab UK COAs are issued by Optima Labs (UK), an independent analytical chemistry facility, and ship with every order. See our full Research Quality Standards SOP.
BPC-157 reference content on Peptides Lab UK
- BPC-157 UK Complete Research Guide 2026 — the primary mechanism + evidence reference.
- Buy BPC-157 UK — research-grade SKU, COA per batch.
- KLOW blend (BPC + TB500 + GHK + KPV) 80 mg — combination research SKU.
- Research-Grade Peptides Buyer’s Guide — what makes a peptide research-grade.
- Reconstitution calculator — UK U-100 syringe unit converter.
FAQs — BPC-157 in UK research
What is BPC-157?
BPC-157 (Body Protection Compound 157) is a 15-amino-acid synthetic peptide fragment derived from a protective protein found in human gastric juice. It is studied in laboratory research for roles in angiogenesis modulation, growth factor receptor activation, and cytoprotective signalling.
Is BPC-157 legal in the UK?
BPC-157 is not a controlled substance under the UK Misuse of Drugs Act 1971 and may be supplied for laboratory research use only. It is not authorised by the MHRA for human medicinal use.
What purity does Peptides Lab UK BPC-157 ship at?
Every batch is independently HPLC-tested by Optima Labs (UK) at typical 99.0–99.7% purity, with mass-spectrometry identity confirmation and bacterial endotoxin quantification.
How is BPC-157 reconstituted?
Lyophilised BPC-157 is reconstituted in laboratory settings with bacteriostatic water. Use the Peptides Lab UK reconstitution calculator.
Do you ship BPC-157 next-day in the UK?
Yes — orders placed before 14:00 UK time on a working day ship same day via Royal Mail Tracked 24.
Last updated: 26 April 2026. Reviewed by William, Lead Research Editor, Peptides Lab UK. For in-vitro and preclinical research use only.
